PREVALENCE AND PREDICTORS OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN A RETROSPECTIVE COHORT OF PATIENTS WITH ULCERATIVE COLITIS

被引：0
|
作者：
Elmoursi, Ahmed
Ali, Mohamed
Metawea, Ibrahim
Alareidi, Alaa
Abomhya, Ahmed
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [31] Description of a cohort of patients with metabolic dysfunction-associated steatotic liver disease followed at an urban liver centre (Toronto liver centre), high prevalence of extrahepatic conditions
    Shpilevaia, Elizaveta
    Xu, Jason
    Rais, Josh
    Pavic, Eva
    Fragoso, Eva
    Ali, Farah Imdad
    Modarresi, Mehrdad
    Ghafoor, Aleena
    Jammu, Anish
    Magnes, Marzena
    Elkhashab, Magdy
    JOURNAL OF HEPATOLOGY, 2024, 80 : S555 - S555
  • [32] Nomogram for predicting 5-year metabolic dysfunction-associated steatotic liver disease risk: retrospective cohort study
    Gao, Lei
    Cui, Wenxia
    Mu, Dinghuang
    Li, Shaoping
    Li, Nan
    Zhou, Weihong
    Hu, Yun
    ENDOCRINE CONNECTIONS, 2024, 13 (08)
  • [33] Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
    Younossi, Zobair M.
    Golabi, Pegah
    Paik, James
    Owrangi, Soroor
    Yilmaz, Yusuf
    El-Kassas, Mohamed
    Alswat, Khalid
    Alqahtani, Saleh A.
    LIVER INTERNATIONAL, 2024, 44 (04) : 1061 - 1070
  • [34] Time-trends of fibrosis and steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective cohort analysis
    Arora, Umang
    Biswas, Sagnik
    Dwarkanathan, Vignesh
    Sheikh, Sabreena
    Agarwal, Ayush
    Aggarwal, Arnav
    Mehta, Shubham
    Shalimar, Shalimar
    JOURNAL OF HEPATOLOGY, 2024, 80 : S506 - S506
  • [35] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
    Paklar, Natasa
    Mijic, Maja
    Filipec-Kanizaj, Tajana
    BIOMEDICINES, 2023, 11 (11)
  • [36] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [37] Platelet dynamics in metabolic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and liver cirrhosis
    Zoncape, Mirko
    Castelli, Marco
    Sacerdoti, David
    Minuz, Pietro
    Dalbeni, Andrea
    JOURNAL OF HEPATOLOGY, 2024, 80 : S492 - S493
  • [38] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [39] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [40] Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
    Armandi, Angelo
    Bugianesi, Elisabetta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 20 - 27
12345